Iter-4360dd15-0084-transcript
第 84 轮执行轨迹
→ call search_memory({"limit":10,"query":"4360dd15 NEXT_FOCUS 原始人类试验 综述 引用链 主要终点 死亡 生存 健康寿命 失能自由生存"}) → call list_recent({"n":8})
→ call list_by_tag({"limit":20,"tag":"4360dd15"})
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0060-transcript", "tags": "iteration transcript", "modified": "20260424200117000", "preview": "!! 第 60 轮执行轨迹
→"}, {"title": "Iter-4360dd15-0083-transcript", "tags": "iteration transcript", "modified": "20260424204550000", "preview": "!! 第 83 轮执行轨迹 → call search_"}, {"title": "Iter-4360dd15-0059-transcript", "tags": "iteration transcript", "modified": "20260424195947000", "preview": "!! 第 59 轮执行轨迹 【tool:list_recent】
{"ok": true, "items": [{"title": "Iter-4360dd15-0083-reflection", "modified": "20260424204557000", "tags": "iteration reflection"}, {"title": "NEXT_FOCUS", "modified": "20260424204557000", "tags": "pinned focus"}, {"title": "综述只能当入口，不能当证据", "modified": "20260424204557000", "tags": "lesson classification citation-chain trial-audit"}, {"title": "Iter-4360dd15-0083-transcript", "modified": "20260424204550000", "tags": "iteration transcript"}, {"title": "PMID 27883166 is a pilot safety feasibility trial not direct longevity evidence", "modified": "20260424204543000", "tags": "4360dd15 fact clinical-trials endpoint-classification longevity"}, {"title": "Error-20260425-044207", "modified": "20260424204207000", "tags": "error iteration"}, {"title": "Error-20260425-044037", "modified": "20260424204037000", "tags": "error iteration"}, {"title": "Error-20260425-043651", "modified": "20260424203651000", "tags": "error iteration"}]}
【tool:list_by_tag】
{"ok": true, "items": [{"title": "PMID 27883166 is a pilot safety feasibility trial not direct longevity evidence", "modified": "20260424204543000"}, {"title": "PEARL trial is not direct longevity evidence", "modified": "20260424203525000"}, {"title": "Iter-4360dd15-0078-two-pmid-evidence-verification", "modified": "20260424203242000"}, {"title": "Iter-4360dd15-0077-unified-longevity-classification-four-pmids", "modified": "20260424203137000"}, {"title": "Iter-4360dd15-0075-abstract-field-extraction-two-pmids", "modified": "20260424202951000"}, {"title": "Iter-4360dd15-0072-review-exclusion-first-rule", "modified": "20260424202103000"}, {"title": "Iter-4360dd15-0071-minimal-audit-rules", "modified": "20260424201843000"}, {"title": "Iter-4360dd15-0069-standardized-audit-table-two-trials", "modified": "20260424201621000"}, {"title": "Iter-4360dd15-0068-abstract-endpoint-extraction", "modified": "20260424201407000"}, {"title": "Iter-4360dd15-0067-abstract-endpoints-aging-criteria", "modified": "20260424201141000"}, {"title": "Iter-4360dd15-0066-TierA-abstracts-and-endpoints-for-aging-criteria", "modified": "20260424200925000"}, {"title": "Iter-4360dd15-0065-minimal-relevance-decision-rules-for-retained-mtor-trials", "modified": "20260424200748000"}, {"title": "Iter-4360dd15-0064-relevance-tiering-10-pmids", "modified": "20260424200602000"}, {"title": "Iter-4360dd15-0063-10-pmid-audit-table", "modified": "20260424200432000"}, {"title": "Iter-4360dd15-0062-pubmed-title-verificatio
→ call read_note({"title":"NEXT_FOCUS"})
→ call read_note({"title":"Iter-4360dd15-0083-reflection"})
→ call read_note({"title":"Iter-4360dd15-0083-transcript"})
→ call read_note({"title":"Iter-4360dd15-0078-two-pmid-evidence-verification"})
【tool:read_note】
{"ok": true, "title": "NEXT_FOCUS", "tags": "pinned focus", "text": "!! 下轮焦点（来自 mission 4360dd15 · Iter-0083）\n\n只追踪综述引用链中的 1 个未审计原始人类试验 PMID，并确认其主要终点是否直接涉及死亡、生存、健康寿命或失能自由生存。"}
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0083-reflection", "tags": "iteration reflection", "text": "!! 本轮进展\n本轮再次确认 38310895 只是综述并把任务焦点继续压缩到“从综述引用链中找一个尚未审计的原始人类试验并核对其主要终点”。\n\n!! 失败 / 盲点\n仍停留在二次文献与检索线索层面，没有落到任何一个新的原始试验 PMID 上，导致证据增量为零。\n\n!! 下轮焦点\n只追踪综述引用链中的 1 个未审计原始人类试验 PMID，并确认其主要终点是否直接涉及死亡、生存、健康寿命或失能自由生存。\n"}
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0083-transcript", "tags": "iteration transcript", "text": "!! 第 83 轮执行轨迹\n\n
\n → call search_memory({\"limit\":10,\"query\":\"4360dd15 原始人类试验 PMID 综述 引用链 主要终点 生存 健康寿命 失能自由生存\"})\n\n → call list_recent({\"n\":8})\n\n → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"})\n\n【tool:search_memory】\n{\"ok\": true, \"results\": [{\"title\": \"Iter-4360dd15-0060-transcript\", \"tags\": \"iteration transcript\", \"modified\": \"20260424200117000\", \"preview\": \"!! 第 60 轮执行轨迹 →\"}, {\"title\": \"Iter-4360dd15-0059-transcript\", \"tags\": \"iteration transcript\", \"modified\": \"20260424195947000\", \"preview\": \"!! 第 59 轮执行轨迹 【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0078-two-pmid-evidence-verification", "tags": "4360dd15 knowledge fact classification", "text": "!! 第 78 轮：剩余两个 PMID 的证据核验与最终判定\n\n本轮只做一件事：用可公开访问的 web snippet 再核对剩余两个候选 PMID 的研究类型、年龄判据和主要终点，并把保留/排除判定钉死。\n\n!! PMID 35040506\n- 题名：mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis\n- 研究类型：randomized, double-blind, placebo-controlled futility trial；并带 1-year biomarker longitudinal analysis\n- 年龄判据：ClinicalTrials.gov / 公开页面与先前抽取一致，入组年龄 30–80 岁\n- 主要终点：48-week change in UMSARS total score\n- 判定：排除，原因不是后续分析，而是疾病特异性神经退行病试验，终点为 UMSARS，而非寿命/死亡/健康寿命\n- 可核对来源：\n - PubMed: https://pubmed.ncbi.nlm.nih.gov/35040506/?dopt=Abstract\n - Europe PMC: https://europepmc.org/article/MED/35040506\n - PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018525/\n - web snippet 明确给出 “Objective: To investigate the efficacy and safety of sirolimus in patients with MSA using a futility design. We also analyzed 1-year biomarker trajectories in the trial participants.”\n\n!! PMID 29992557\n- 题名：Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial\n- 研究类型：open-label, single-arm, phase IIIB trial\n- 年龄判据：postmenopausal women\n- 主要终点：progression-free survival (PFS) / overall response rate（公开 tri
→ call web_search({"limit":10,"query":"\"mTOR inhibition improves immune function in the elderly\" PubMed PMID Mannick"})
→ call web_search({"limit":10,"query":"Mannick elderly mTOR inhibition immune function trial PubMed"})
→ call search_memory({"limit":20,"query":"Mannick elderly mTOR inhibition immune function PMID"})
【tool:web_search】
{"ok": true, "query": "\"mTOR inhibition improves immune function in the elderly\" PubMed PMID Mannick", "results": [{"title": "mTOR inhibition improves immune function in the elderly - AAAS", "url": "https://www.science.org/doi/pdf/10.1126/scitranslmed.3009892?download=true", "snippet": "*Corresponding author. E-mail: joan.mannick@novartis.com lymphocytes, an improved response to influenza vaccination, and extended life span ( ). On the basis of these findings, we investi- 10 gated whether a 6-week treatment with the mTOR inhibitor RAD001, an analog of rapamycin, improved the response to influenza vaccination in elderly volunteers."}, {"title": "mTOR inhibition improves immune function in the elderly", "url": "https://www.ovid.com/journals/stmed/fulltext/10.1126/scitranslmed.3009892~mtor-inhibition-improves-immune-function-in-the-elderly", "snippet": "Inhibition of the mammalian target of rapamycin (mTOR) pathway extends life span in all species studied to date, and in mice delays the onset of age-related diseases and comorbidities. However, it is unknown if mTOR inhibition affects aging or its consequences in humans. To begin to assess the effects of mTOR inhibition on human aging-related conditions, we evaluated whether the mTOR inhibitor ..."}, {"title": "Mtor Inhibition Improves Immune Function in The Elderly", "url": "https://academic.oup.com/gerontologist/article/56/Suppl_3/686/2576322", "snippet": "Inhibition of the mTOR pathway extends lifespan in all species studied
【tool:web_search】
{"ok": true, "query": "Mannick elderly mTOR inhibition immune function trial PubMed", "results": [{"title": "PubMed", "url": "https://pubmed.ncbi.nlm.nih.gov/", "snippet": "PubMed ® comprises more than 40 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites."}, {"title": "mTOR inhibition improves immune function in the elderly", "url": "https://www.science.org/doi/10.1126/scitranslmed.3009892", "snippet": "To begin to address this question, Mannick et al. evaluated the effects of the mTOR inhibitor RAD001 on the decline in immune function that occurs during aging in humans. Their findings suggest that RAD001 improved immune function in elderly volunteers as assessed by response to influenza vaccination."}, {"title": "PDF mTOR inhibition improves immune function in the elderly", "url": "https://health.uconn.edu/aging/wp-content/uploads/sites/6/2016/04/mTOR-inhibition-improves-immune-function-in-the-elderly.pdf", "snippet": "To begin to assess the effects of mTOR inhibition on human aging-related conditions, we evaluated whether the mTOR inhibitor RAD001 ameliorated immunosenescence (the decline in immune function during aging) in elderly volunteers, as assessed by their response to influenza vaccination."}, {"title": "PDF mTOR inhibition improves immune function in the elderly", "url": "https://www.researchgate.net/profile/Joan-Mannick/publ
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0065-transcript", "tags": "iteration transcript", "modified": "20260424200755000", "preview": "!! 第 65 轮执行轨迹
→ call search_memory({\"limit\":10,\"query\":\"4360dd15 NEXT_FOCUS 10 条 PMID 相关性 分层 判据\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) → call list_tools({}) 【tool:search_memory】 {\"ok\": true, \"results\": [{\"title\": \"Iter-4360dd15-0060-transcript\", \"tags\": \"iteration transcript\", \"modified\": \"20260424200117000\", \"preview\": \"!! 第 60 轮执行轨迹 → call search_memory({\"limit\":10,\"query\":\"4360dd15 原始人类试验 PMID 综述 引用链 主要终点 生存 健康寿命 失能自由生存\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) 【tool:search_memory】 {\"ok\": true, \"results\": [{\"title\": \"Iter-4360dd15-0060-transcript\", \"tags\": \"iteration transcript\", \"modified\": \"20260424200117000\", \"preview\": \"!! 第 60 轮执行轨迹 → call search_memory({\"limit\":8,\"query\":\"4360dd15 33977284 29408453 abstract endpoint aging criteria\"}) 【tool:search_memory】 {\"ok\": true, \"results\": [{\"title\": \"Iter-4360dd15-0060-transcript\", \"tags\": \" → call pubmed_search({"limit":5,"query":"25540326"})
→ call web_fetch({"max_chars":7000,"url":"https://europepmc.org/abstract/med/25540326"})
→ call web_search({"limit":8,"query":"PMID 25540326 primary endpoint influenza vaccination response elderly RAD001"})
【tool:pubmed_search】
{"ok": true, "query": "25540326", "results": [{"pmid": "25540326", "title": "mTOR inhibition improves immune function in the elderly.", "source": "Sci Transl Med", "pubdate": "2014 Dec 24", "authors": ["Mannick JB", "Del Giudice G", "Lattanzi M", "Valiante NM", "Praestgaard J", "Huang B", "Lonetto MA", "Maecker HT"], "url": "https://pubmed.ncbi.nlm.nih.gov/25540326/"}]}
【tool:web_fetch】
{"ok": true, "url": "https://europepmc.org/article/med/25540326", "status": 200, "content_type": "text/html;charset=UTF-8", "text": "Europe PMC Europe PMC 1 Sign in | Create an account https://orcid.org https://plus.europepmc.org Europe PMC Menu About About Europe PMC Preprints in Europe PMC Funders Become a funder Governance Roadmap Outreach Tools Tools overview Article status monitor Grant finder External links service RSS feeds About SciLite annotations Annotations submission service Developers Developer resources Articles RESTful API Grants RESTful API API case studies SOAP web service Annotations API OAI service Bulk downloads Developers Forum Support User guide Search syntax guide Contact us Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus NOTICE: The ORCID Claiming tool has been temporarily disabled, because of technical issues. Please check back in later.", "truncated": false}
【tool:web_search】
{"ok": true, "query": "PMID 25540326 primary endpoint influenza vaccination response elderly RAD001", "results": [{"title": "Effectiveness of influenza vaccination in the elderly: a population ...", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8860060/", "snippet": "The risks of hospitalisation, physician visits and emergency department visits for influenza and pneumonia in the elderly population aged 65 years and over are significantly increased during influenza seasons. 1 As recommended by the WHO, influenza vaccination is the major strategy to control influenza in high-risk populations. 2 The vaccines ..."}, {"title": "Influenza vaccination for elderly, vulnerable and high-risk subjects: a ...", "url": "https://link.springer.com/article/10.1007/s11739-023-03456-9", "snippet": "Influenza is associated with a substantial health burden, especially in high-risk subjects such as older adults, frail individuals and those with underlying chronic diseases. In this review, we summarized clinical findings regarding the impact of influenza in vulnerable populations, highlighted the benefits of influenza vaccination in preventing severe illness and complications and reviewed ..."}, {"title": "Distinct immunological and molecular signatures underpinning influenza ...", "url": "https://www.nature.com/articles/s41467-022-34487-z", "snippet": "Seasonal influenza vaccination is an important strategy to prevent serious disease in the elderly , but individual responsiveness to vaccinatio
→ call web_search({"limit":10,"query":"\"25540326\" \"primary endpoint\" influenza vaccination response elderly"})
→ call web_search({"limit":10,"query":"\"mTOR inhibition improves immune function in the elderly\" \"influenza vaccination\" \"primary endpoint\""})
→ call search_memory({"limit":10,"query":"25540326 endpoint vaccination elderly immune function primary endpoint"})
【tool:web_search】
{"ok": true, "query": "\"25540326\" \"primary endpoint\" influenza vaccination response elderly", "results": []}
【tool:web_search】
{"ok": true, "query": "\"mTOR inhibition improves immune function in the elderly\" \"influenza vaccination\" \"primary endpoint\"", "results": []}
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0010-transcript", "tags": "iteration transcript", "modified": "20260424175830000", "preview": "!! 第 10 轮执行轨迹
→ cal"}, {"title": "Iter-4360dd15-0077-transcript", "tags": "iteration transcript", "modified": "20260424203143000", "preview": "!! 第 77 轮执行轨迹 → call search_memory({"}, {"title": "Iter-4360dd15-0007-transcript", "tags": "iteration transcript", "modified": "20260424174944000", "preview": "!! 第 7 轮执行轨迹 → call web_search({"limit":10,"query":"\"mTOR inhibition improves immune function in the elderly\" trial response to influenza vaccination primary endpoint"})
→ call web_search({"limit":10,"query":"\"25540326\" \"response to influenza vaccination\""})
→ call web_search({"limit":10,"query":"\"mTOR inhibition improves immune function in the elderly\" \"elderly volunteers\" influenza vaccination"})
→ call web_search({"limit":10,"query":"site:clinicaltrials.gov mTOR inhibition improves immune function in the elderly RAD001 influenza"})
【tool:web_search】
{"ok": true, "query": "\"mTOR inhibition improves immune function in the elderly\" trial response to influenza vaccination primary endpoint", "results": [{"title": "mTOR inhibition improves immune function in the elderly", "url": "https://www.science.org/doi/10.1126/scitranslmed.3009892", "snippet": "Their findings suggest that RAD001 improved immune function in elderly volunteers as assessed by response to influenza vaccination . It remains to be determined whether mTOR inhibition improves additional aging-related conditions in humans."}, {"title": "mTOR inhibition improves immune function in the elderly", "url": "https://www.researchgate.net/publication/270002631_mTOR_inhibition_improves_immune_function_in_the_elderly", "snippet": "The bold black line indicates the 1.2-fold increase in titers relative to placebo that is required for two of three influenza vaccine strains in order to meet the primary endpoint of the study."}, {"title": "Mtor Inhibition Improves Immune Function in The Elderly", "url": "https://academic.oup.com/gerontologist/article/56/Suppl_3/686/2576322", "snippet": "However, it is unknown if mTOR inhibition affects aging in humans. To begin to assess the effects of mTOR inhibition on human aging-related conditions, we evaluated whether the mTOR inhibitor RAD001 ameliorated immunosenescence (the decline in immune function during aging) in elderly subjects, as assessed by response to influenza vaccination ."}, {"title": "mTOR inhibition improves immune functi
【tool:web_search】
{"ok": true, "query": "\"25540326\" \"response to influenza vaccination\"", "results": []}
【tool:web_search】
{"ok": true, "query": "\"mTOR inhibition improves immune function in the elderly\" \"elderly volunteers\" influenza vaccination", "results": []}
【tool:web_search】
{"ok": true, "query": "site:clinicaltrials.gov mTOR inhibition improves immune function in the elderly RAD001 influenza", "results": []}
→ call write_note({"tags":["4360dd15","fact","classification","clinical-trials","longevity"],"text":"!! 第 84 轮：对 PMID 25540326 的反证性审计\n\n- PMID：25540326\n- 题名：''mTOR inhibition improves immune function in the elderly.''\n- 公开摘要/网页抓取显示：研究对象是 elderly volunteers / elderly subjects；研究目的为评估 RAD001（rapalog）是否改善 immune function 与 response to influenza vaccination。\n- 公开 snippet 还给出主要终点的判据：需要在三种流感疫苗株中至少两种达到相对 place)
【tool:write_note】
{"ok": true, "path": "C:\\Users\\yh599\\Documents\\GitHub\\LLM-yh\\Sisyphus\\wiki\\tiddlers\\PMID_25540326_is_immune-response_endpoint_not_longevity_evidence.tid", "title": "PMID 25540326 is immune-response endpoint, not longevity evidence"}
【assistant】
第 84 轮：我没有再被“标题像长寿”迷惑。
**本轮子任务**
- 只审计一个高风险 PMID：**25540326**
- 核对其**主要终点**是否直接涉及死亡 / 生存 / 健康寿命 / 失能自由生存
**审计结果**
- PMID 25540326 = **mTOR inhibition improves immune function in the elderly**
- 公开 snippet 显示其主要终点是：
- 流感疫苗抗体反应
- immune function / immunosenescence
- 甚至有明确的 **1.2-fold titer** 判据
- 这说明它是**免疫反应/生物标志物试验**，不是直接 longevity evidence
- 结论：**排除**
**严厉点评**
- 这是典型的“伪长寿试验”陷阱：
年龄大、mTOR 抑制剂、标题带 aging 语义，但终点仍然只是疫苗反应。
- 以后凡是看到 **vaccine response / antibody titer / biomarker / immune marker**，默认先按非长寿证据处理，别再浪费轮次。
**已沉淀**
- 写入记忆：PMID 25540326 is immune-response endpoint, not longevity evidence
<NEXT_FOCUS>沿综述引用链继续只审计 1 个尚未审计的原始人类试验 PMID，优先挑“标题含 elderly/aging 但终点可能被误判”的那一个，并验证其主要终点是否真的涉及死亡、生存、健康寿命或失能自由生存。</NEXT_FOCUS>
```